Lung cancer after heart transplantation: Results from a large multicenter registry

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 1035-1040

  Crespo Leiro, M G ^a   Villa Arranz, A ^b   Manito Lorite, N ^c   Paniagua Martin, M J ^a   Rabago G ^d   Almenar Bonet, L ^e   Alonso Pulpon L ^f   Mirabet Perez S ^g   Diaz Molina, B ^h   Gonzalez Vilchez F ⁱ   Arizon De Prado J M ^j   Romero Rodriguez, N ^k   Delgado Jimenez, J ^l   Roig, E ^m   Blasco Peiro T ⁿ   Pascual Figal, D ^o   De La Fuente Galan L ^p   Muniz J ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j Hospital Universitario Reina Sofia Cordoba   (Argentina)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m HOSPITAL CLÍNIC   (Spain)

ⁿ HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^o HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^p HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

more..

Author keywords

Heart transplantation; lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; AGED; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REGISTRIES; SEX FACTORS; SPAIN;

EID: 79955547141     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03515.x     Document Type: Article

References (31)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D,. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase. In: No. 10 [Internet]. International Agency for Research on Cancer; 2010. Available from: ]. Lyon, France; 2010.
2. Crespo-Leiro MG, Alonso-Pulpon L, Vazquez de Prada JA, et al,. Malignancy after heart transplantation: Incidence, prognosis and risk factors. Am J Transplant 2008; 8: 1031-1039. (Pubitemid 351537770)
3. O'Neill JO, Edwards LB, Taylor DO,. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 1186-1191. (Pubitemid 44528284)
4. Jensen P, Hansen S, Moller B, et al,. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40 (2 Pt 1): 177-186. (Pubitemid 29072794)
5. Swerdlow A, Higgins G, Hunt B, et al,. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus. Transplantation 2000; 69: 897-904. (Pubitemid 30174118)
6. Roithmaier S, Haydon AM, Loi S, et al,. Incidence of malignancies in heart and/or lung transplant recipients: A single-institution experience. J Heart Lung Transplant 2007; 26: 845-849. (Pubitemid 47214568)
7. Kellerman L, Neugut A, Burke B, Mancini D,. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Am J Cardiol 2009; 103: 562-566.
8. Jiang Y, Villeneuve PJ, Wielgosz A, Schaubel DE, Fenton SS, Mao Y,. The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant 2010; 10: 637-645.
9. Serraino D, Piselli P, Busnach G, et al,. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007; 43: 2117-2123. (Pubitemid 47381577)
10. Segi M,. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohoku University School of Public Health, 1960.
11. Ferlay J, Bray F, Pisani P, Parkin D,. GLOBOCAN 2002, cancer incidence, mortality and prevalence worldwide. In: IARC cancer base No. 5 version 2.0. in May 2010]). Lyon, France: IARC Press 2004; 2004.
12. Clayton D, Hills M,. Statistical models in epidemiology. Oxford: Oxford University Press, 1993.
13. Rosner B,. Fundamentals of biostatistics, 5th Ed., Belmont, CA: Duxbury Press, 2000.
14. Hervada Vidal X, Santiago Pérez M, Vázquez Fernández E, Castillo Salgado C, Loyola Elizondo E, Silva Ayçaguer L,. Epidat 3.0: Programa para el análisis epidemiológico de datos tabulados. Versión 3.0. Rev Esp Salud Pública 2004; 78: 277-280.
15. Fay M, Feuer E,. Confidence intervals for directly standardized rates: A method based on the gamma distribution. Stat Med 1997; 16: 791-801. (Pubitemid 27165684)
16. Collett D, Mumford L, Banner NR, Neuberger J, Watson C,. Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit. Am J Transplant 2010; 10: 1889-1896.
17. Adami J, Gabel H, Lindelof B, et al,. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227. (Pubitemid 37363407)
18. Brewer JD, Colegio OR, Phillips PK, et al,. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145: 1391-1396.
19. Goldstein D, Austin J, Zuech N, et al,. Carcinoma of the lung after heart transplantation. Transplantation 1996; 62: 772-775. (Pubitemid 26332841)
20. Rinaldi M, Pellegrini C, D'Armini AM, et al,. Neoplastic disease after heart transplantation: Single center experience. Eur J Cardiothorac Surg 2001; 19: 696-701. (Pubitemid 32416623)
21. Anyanwu AC, Townsend ER, Banner NR, Burke M, Khaghani A, Yacoub MH,. Primary lung carcinoma after heart or lung transplantation: Management and outcome. J Thorac Cardiovasc Surg 2002; 124: 1190-1197. (Pubitemid 35417007)
22. Consumo MdSy. Encuesta Nacional de Salud de España 2001; 2004.
23. Villalbí J, Ariza C,. El tabaquismo en España: Situación actual y perspectivas para el movimiento de prevención. In:, Ariza C, Villalbí J, eds. El tabaquismo en España: situación actual y perspectivas para el movimiento de prevención. Barcelona: CNPT y SESPAS, 2000: 3-15.
24. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R,. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. BMJ 2000; 321: 323-329. (Pubitemid 30496873)
25. USDHHS. The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Atlanta U.S. 1990.
26. Bruschi G, Conforti S, Torre M, et al,. Long-term results of lung cancer after heart transplantation: Single center 20-year experience. Lung Cancer 2009; 63: 146-150.
27. Mohammadi S, Bonnet N, Leprince P, et al,. Long-term survival of heart transplant recipients with lung cancer: The role of chest computed tomography screening. Thorac Cardiovasc Surg 2007; 55: 438-441. (Pubitemid 350013797)
28. Miao Y, Everly JJ, Gross TG, Tevar AD, First MR, Alloway RR, Woodle ES,. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 2009; 87: 1347-1359.
29. Padilla J, Ceron J, Penalver JC, Jorda C, Pastor E, de Aguiar K,. [Bronchogenic carcinoma in patients undergoing solid organ transplant. The role of surgery.]. Cir Esp 2009; 86: 101-104.
30. Xing L, Todd NW, Yu L, Fang H, Jiang F,. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010; 23: 1157-1164.
31. Varella-Garcia M, Schulte AP, Wolf HJ, et al,. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) 2010; 3: 447-453.